According to this study based on the expression of C-X-C motif chemokine ligand 12 (CXCL12) and CXCR7 mRNA, chemotherapy/MF/PTT combined therapy exhibited the greatest reduction in breast cancer metastatic activity. This evidence concerns the gene CXCL12 and breast cancer.